Active

Panacea Pharma

Switched

BE0501960053

Rechtspersoon Private limited company 1 establishment

Lierbaan 37, 2580 Putte Activiteiten van holdings

Active for

13 year, 8 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 111,948

▲ 68% vs 2024

Profit

Healthy

€ 63,348

▼ 45% vs 2024

Debts

Low

€ 556,672

▼ 11% vs 2024

Panacea Pharma from Putte, company number BE0501960053, closed financial year 2025 with a result of € 63,348 after tax. For that financial year Panacea Pharma recorded a gross margin of € 111,948 and equity of € 1 million. Compared with financial year 2024, the result moved from € 114,285 to € 63,348. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 28, 2025.

What happened at Panacea Pharma?

What happened at Panacea Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 63,348 (▼ 45% vs 2024). Source: NBB ↗
  • New establishment in Putte. KBO
  • Stefan Puttemans became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 189,414 profit in 2022 to € 63,348 profit in 2025.

Paid € 86,892 in corporate taxes since 2022.

Best year ever: 2022, with € 189,414 profit.

Paid out € 54,600 in dividends to the owners in total.

A new publication or filing at Panacea Pharma? We notify you, reason included.

Follow Panacea Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Stefan Puttemans
Panacea Pharma

Behind Panacea Pharma is Stefan Puttemans. It owns 94.9% of Apotheek Puttemans-Vernaillen itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Stefan Puttemans

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Lierbaan 37

2580 Putte

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0501.960.053
VAT number
BE 0501.960.053
Registered office
Lierbaan 37, 2580 Putte
Names & denominations
Panacea Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
10 December 2012
Peppol
Active · Active since 8 Dec 2025
Activities · NACE

Activiteiten van holdings

Holdings

Groothandel in farmaceutische en medische artikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Overige zakelijke dienstverlening, neg

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Handel in eigen onroerend goed

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

+1

Frequently asked questions

What is the enterprise number of Panacea Pharma?
The enterprise number of Panacea Pharma is BE0501960053.
What is the address of Panacea Pharma?
The registered office of Panacea Pharma is located at Lierbaan 37, 2580 Putte.
When was Panacea Pharma founded?
Panacea Pharma was founded on 10 December 2012.
What is the main activity of Panacea Pharma?
The main activity of Panacea Pharma is "Activiteiten van holdings" (NACE code 64210).
Does Panacea Pharma have a website?
No website is currently known for Panacea Pharma.
How much profit did Panacea Pharma make in 2025?
Panacea Pharma posted a profit after taxes of € 63,348 in financial year 2025.
What is the revenue of Panacea Pharma?
As a small company, Panacea Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 111,948.
Where can I find the annual accounts of Panacea Pharma?
Panacea Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Panacea Pharma?
According to the 2025 annual accounts, the directors of Panacea Pharma are: Stefan Puttemans.
Who owns Panacea Pharma?
Behind Panacea Pharma is Stefan Puttemans. It owns 94.9% of Apotheek Puttemans-Vernaillen itself.